• Skip to primary navigation
  • Skip to content
  • Skip to footer

Bionor Holding AS

  • About us
  • Functional HIV cure
  • Platform technology
  • Investors
  • News
  • Functional HIV cure
  • Vacc-4x vaccine
  • Vacc-C5 vaccine
  • Platform technology

News

News by the year

  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • Change of name to Bionor Holding AS

    Posted in Investors 29.01.2018

    Oslo, January 29.1.2018 In an Extraordinary General Meeting today, the shareholders unanimously adopted to change the name of the company from Bionor Pharma AS to Bionor Holding AS.  The change […]


    Birger Sørensen and his team closed the purchase and funding of Bionor today

    Posted in Investors 8.12.2017

    Oslo, December 8, 2017 Bionor was purchased by the founder of Bionor AS, Birger Sørensen and his team, on September 28, 2017 with financial closing as of today. With the […]


    Strategic partnership between Smerud Medical Research International and Bionor

    Posted in Investors 24.11.2017

    Oslo, November 24, 2017 Bionor is proud to announce that the company on November 24 entered into a strategic partnership with Smerud Medical Research International (SMRI). This partnership will focus […]


    • Page 1
    • Page 2
    • Page 3
    • …
    • Page 21
    • Next Page »

    Footer

    • About us
    • Functional HIV cure
    • Platform technology
    • Investors
    • News

    Follow us

    Bionor Holding AS
    Bryggegata 6 – P.O. Box 11 – NO-0250 Oslo – Norway
    post@bionorholding.com